Skip to main content
main-content
Erschienen in: Intensive Care Medicine 4/2007

01.04.2007 | Brief Report

Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients

verfasst von: Steffen Weber-Carstens, Maria Deja, Sven Bercker, Anna Dimroth, Olaf Ahlers, Udo Kaisers, Didier Keh

Erschienen in: Intensive Care Medicine | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

Objective

To determine whether glycemic control is less feasible when hydrocortisone is given as a bolus compared with continuous application in septic shock patients.

Design

Observational prospective pilot study.

Setting

Fourteen-bed surgical university hospital ICU.

Patients

Sixteen consecutive patients with septic shock receiving a continuous infusion of 200 mg hydrocortisone/day and an infusion regime of insulin keeping blood glucose below 150 mg/dl.

Intervention

Blood glucose and insulin infusion were adjusted to steady state before intervention. At baseline, the continuous hydrocortisone infusion was replaced with a single bolus of 50 mg hydrocortisone. During a subsequent 6-h period, blood glucose was monitored hourly and insulin infusion was kept constant. Afterwards, hydrocortisone application and adjustment of blood glucose was resumed according to standard treatment.

Results

Mean blood glucose in steady state at baseline immediately prior to intervention was 128 mg/dl (range 114–141 mg/dl; 95% confidence interval). After bolus injection of hydrocortisone, blood glucose increased significantly within 6 h with peak levels of 154 mg/dl (range 132–178 mg/dl; p < 0.01). Blood glucose returned to baseline with restoration of continuous hydrocortisone infusion. There were marked inter-individual variations with peak glucose values up to 254 mg/dl, but no significant difference in intra-individual glucose variability before and after bolus injection of hydrocortisone.

Conclusions

Bolus injections of hydrocortisone may induce significant increases of blood glucose in patients with septic shock. The individual response is highly variable and we speculate that repetitive boluses would induce marked undulation of blood glucose. In terms of glycemic-control strategies, a continuous infusion of hydrocortisone seems to be preferable.
Literatur
1.
Zurück zum Zitat van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367 PubMedCrossRef van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367 PubMedCrossRef
2.
Zurück zum Zitat van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461 PubMedCrossRef van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461 PubMedCrossRef
3.
Zurück zum Zitat Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM et al. (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30:536–555 PubMedCrossRef Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM et al. (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30:536–555 PubMedCrossRef
4.
Zurück zum Zitat Keh D, Sprung CL (2004) Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review. Crit Care Med 32:S527–S533 PubMedCrossRef Keh D, Sprung CL (2004) Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review. Crit Care Med 32:S527–S533 PubMedCrossRef
5.
Zurück zum Zitat Marik PE, Raghavan M (2004) Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 30:748–756 PubMedCrossRef Marik PE, Raghavan M (2004) Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 30:748–756 PubMedCrossRef
6.
Zurück zum Zitat McMullin J, Brozek J, Jaeschke R, Hamielec C, Dhingra V, Rocker G, Freitag A, Gibson J, Cook D (2004) Glycemic control in the ICU: a multicenter survey. Intensive Care Med 30:798–803 PubMedCrossRef McMullin J, Brozek J, Jaeschke R, Hamielec C, Dhingra V, Rocker G, Freitag A, Gibson J, Cook D (2004) Glycemic control in the ICU: a multicenter survey. Intensive Care Med 30:798–803 PubMedCrossRef
7.
Zurück zum Zitat Kanji S, Singh A, Tierney M, Meggison H, McIntyre L, Hebert PC (2004) Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med 30:804–810 PubMedCrossRef Kanji S, Singh A, Tierney M, Meggison H, McIntyre L, Hebert PC (2004) Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med 30:804–810 PubMedCrossRef
8.
Zurück zum Zitat Weber-Carstens S, Deja M, Hokema F, Dimroth A, Kaisers U, Falke K, Keh D (2005) Impact of continuous versus bolus low-dose hydrocortisone application on blood glucose in septic shock patients. Critical Care 9:P389 CrossRef Weber-Carstens S, Deja M, Hokema F, Dimroth A, Kaisers U, Falke K, Keh D (2005) Impact of continuous versus bolus low-dose hydrocortisone application on blood glucose in septic shock patients. Critical Care 9:P389 CrossRef
9.
Zurück zum Zitat Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655 PubMed Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655 PubMed
10.
Zurück zum Zitat Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y (2004) Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. Br Med J 329:480 CrossRef Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y (2004) Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. Br Med J 329:480 CrossRef
11.
Zurück zum Zitat Egi M, Bellomo R, Stachowski E, French CJ, Hart G (2006) Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 105:244–252 PubMedCrossRef Egi M, Bellomo R, Stachowski E, French CJ, Hart G (2006) Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 105:244–252 PubMedCrossRef
Metadaten
Titel
Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients
verfasst von
Steffen Weber-Carstens
Maria Deja
Sven Bercker
Anna Dimroth
Olaf Ahlers
Udo Kaisers
Didier Keh
Publikationsdatum
01.04.2007
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 4/2007
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-007-0540-3